23 May 2013
Keywords: merck, co, in-licenses, novel, osteoanabolic, drug, japan
Article | 29 September 2008
US drug major Merck & Co and Japan Tobacco have entered a worldwide licensing agreement to develop and commercialize JTT-305, an
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 September 2008
6 October 2008
22 September 2008
© 2013 thepharmaletter.com